Bill Text: NY A06799 | 2023-2024 | General Assembly | Amended
Bill Title: Establishes a drug-induced movement disorder screening education program; provides that the department shall develop such program to educate the public about the importance of screening for drug-induced movement disorders, develop and disseminate educational materials for healthcare providers regarding treatment for drug-induced movement disorders, and eliminate bias and reduction of stigma for people living with drug-induced movement disorders related to the treatment of mental health conditions.
Spectrum: Partisan Bill (Democrat 3-0)
Status: (Engrossed) 2024-06-06 - RETURNED TO ASSEMBLY [A06799 Detail]
Download: New_York-2023-A06799-Amended.html
STATE OF NEW YORK ________________________________________________________________________ 6799--B 2023-2024 Regular Sessions IN ASSEMBLY May 8, 2023 ___________ Introduced by M. of A. PAULIN, SAYEGH, SEAWRIGHT -- read once and referred to the Committee on Health -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said commit- tee -- recommitted to the Committee on Health in accordance with Assembly Rule 3, sec. 2 -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee AN ACT to amend the public health law, in relation to establishing a drug-induced movement disorder screening education program The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Subdivision 1 of section 207 of the public health law is 2 amended by adding a new paragraph (h) to read as follows: 3 (h) The department shall develop and conduct a program concerning 4 drug-induced movement disorders. Such program shall include but not be 5 limited to, (i) educational information on the importance of screening 6 for and identifying symptoms of drug-induced movement disorders; and 7 (ii) the development and dissemination of educational materials for 8 healthcare providers regarding treatment for drug-induced movement 9 disorders, including for services provided via telehealth. Such educa- 10 tional materials disseminated to healthcare providers shall be developed 11 and disseminated in coordination with relevant healthcare provider 12 groups and shall include best practices for the treatment and screening 13 of movement disorders informed by the American Psychiatric Association 14 and other professional society practice guidelines. Such program shall 15 also include education and outreach on the elimination of stigma for 16 people living with drug-induced movement disorders related to the treat- 17 ment of mental health conditions. 18 § 2. This act shall take effect on the ninetieth day after it shall 19 have become a law. Effective immediately, the addition, amendment and/or 20 repeal of any rule or regulation necessary for the implementation of 21 this act on its effective date are authorized to be made and completed 22 on or before such effective date. EXPLANATION--Matter in italics (underscored) is new; matter in brackets [] is old law to be omitted. LBD10964-05-4